Clinical trial / 2011
Broccoli sprouts powder significantly reduced markers of oxidative stress and increased antioxidant capacity in patients with type 2 diabetes.
In a double-blind trial, 81 patients with type 2 diabetes were randomly assigned to receive 10 g/d broccoli sprouts powder (BSP), 5 g/d BSP, or placebo for 4 weeks, with 63 patients analyzed. Consumption of BSP resulted in a significant decrease in malondialdehyde (P=0.001), oxidized LDL cholesterol (P=0.03), and oxidative stress index (P=0.001), along with a significant increase in total antioxidant capacity (P=0.001). No significant effects were observed on total oxidant status.
- Study type
- Double-blind, placebo-controlled randomized clinical trial
- Who was studied
- 81 patients with type 2 diabetes (63 included in final analysis)
- What was measured
- Serum TAC, TOS, OSI, MDA, and oxidized LDL cholesterol
THE PAPER
Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial.
Bahadoran Z, Mirmiran P, Hosseinpanah F, Hedayati M, Hosseinpour-Niazi S, Azizi F. Eur J Clin Nutr, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.